• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可视化无形之物:无症状传播对新冠疫情动态的影响。

Visualizing the invisible: The effect of asymptomatic transmission on the outbreak dynamics of COVID-19.

作者信息

Peirlinck Mathias, Linka Kevin, Sahli Costabal Francisco, Bhattacharya Jay, Bendavid Eran, Ioannidis John P A, Kuhl Ellen

机构信息

Department of Mechanical Engineering, Stanford University School of Engineering, Stanford, CA, United States.

Department of Mechanical and Metallurgical Engineering and Institute for Biological and Medical Engineering, Schools of Engineering, Biology and Medicine, Pontificia Universidad Catolica de Chile, Santiago, Chile.

出版信息

Comput Methods Appl Mech Eng. 2020 Dec 1;372:113410. doi: 10.1016/j.cma.2020.113410. Epub 2020 Sep 8.

DOI:10.1016/j.cma.2020.113410
PMID:33518823
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7831913/
Abstract

Understanding the outbreak dynamics of the COVID-19 pandemic has important implications for successful containment and mitigation strategies. Recent studies suggest that the population prevalence of SARS-CoV-2 antibodies, a proxy for the number of asymptomatic cases, could be an order of magnitude larger than expected from the number of reported symptomatic cases. Knowing the precise prevalence and contagiousness of asymptomatic transmission is critical to estimate the overall dimension and pandemic potential of COVID-19. However, at this stage, the effect of the asymptomatic population, its size, and its outbreak dynamics remain largely unknown. Here we use reported symptomatic case data in conjunction with antibody seroprevalence studies, a mathematical epidemiology model, and a Bayesian framework to infer the epidemiological characteristics of COVID-19. Our model computes, in real time, the time-varying contact rate of the outbreak, and projects the temporal evolution and credible intervals of the effective reproduction number and the symptomatic, asymptomatic, and recovered populations. Our study quantifies the sensitivity of the outbreak dynamics of COVID-19 to three parameters: the effective reproduction number, the ratio between the symptomatic and asymptomatic populations, and the infectious periods of both groups. For nine distinct locations, our model estimates the fraction of the population that has been infected and recovered by Jun 15, 2020 to 24.15% (95% CI: 20.48%-28.14%) for Heinsberg (NRW, Germany), 2.40% (95% CI: 2.09%-2.76%) for Ada County (ID, USA), 46.19% (95% CI: 45.81%-46.60%) for New York City (NY, USA), 11.26% (95% CI: 7.21%-16.03%) for Santa Clara County (CA, USA), 3.09% (95% CI: 2.27%-4.03%) for Denmark, 12.35% (95% CI: 10.03%-15.18%) for Geneva Canton (Switzerland), 5.24% (95% CI: 4.84%-5.70%) for the Netherlands, 1.53% (95% CI: 0.76%-2.62%) for Rio Grande do Sul (Brazil), and 5.32% (95% CI: 4.77%-5.93%) for Belgium. Our method traces the initial outbreak date in Santa Clara County back to January 20, 2020 (95% CI: December 29, 2019-February 13, 2020). Our results could significantly change our understanding and management of the COVID-19 pandemic: A large asymptomatic population will make isolation, containment, and tracing of individual cases challenging. Instead, managing community transmission through increasing population awareness, promoting physical distancing, and encouraging behavioral changes could become more relevant.

摘要

了解新冠疫情的爆发动态对于成功的防控和缓解策略具有重要意义。近期研究表明,SARS-CoV-2抗体的人群流行率(可作为无症状病例数量的一个指标)可能比报告的有症状病例数量所预期的高出一个数量级。了解无症状传播的精确流行率和传染性对于评估新冠疫情的总体规模和大流行潜力至关重要。然而,在现阶段,无症状人群的影响、其规模及其爆发动态在很大程度上仍然未知。在此,我们结合报告的有症状病例数据、抗体血清流行率研究、一个数学流行病学模型和一个贝叶斯框架来推断新冠疫情的流行病学特征。我们的模型实时计算疫情随时间变化的接触率,并预测有效繁殖数以及有症状、无症状和康复人群的时间演变和可信区间。我们的研究量化了新冠疫情爆发动态对三个参数的敏感性:有效繁殖数、有症状和无症状人群之间的比例以及两组人群的传染期。对于九个不同地点,我们的模型估计,截至2020年6月15日,已感染并康复的人群比例在德国北莱茵-威斯特法伦州海因斯贝格为24.15%(95%置信区间:20.48%-28.14%),美国爱达荷州阿达县为2.40%(95%置信区间:2.09%-2.76%),美国纽约市为46.19%(95%置信区间:45.81%-46.60%),美国加利福尼亚州圣克拉拉县为11.26%(95%置信区间:7.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010f/7831913/6d796ac98135/gr10_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010f/7831913/04ddba0e26a8/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010f/7831913/062ec2381223/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010f/7831913/f7017b59383b/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010f/7831913/eb005e0c744f/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010f/7831913/dc764c384442/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010f/7831913/e665db4cfeb3/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010f/7831913/a989b011ea7e/gr7_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010f/7831913/9b8bf7aeb50e/gr8_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010f/7831913/dcbd7c09d36d/gr9_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010f/7831913/6d796ac98135/gr10_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010f/7831913/04ddba0e26a8/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010f/7831913/062ec2381223/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010f/7831913/f7017b59383b/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010f/7831913/eb005e0c744f/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010f/7831913/dc764c384442/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010f/7831913/e665db4cfeb3/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010f/7831913/a989b011ea7e/gr7_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010f/7831913/9b8bf7aeb50e/gr8_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010f/7831913/dcbd7c09d36d/gr9_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010f/7831913/6d796ac98135/gr10_lrg.jpg

相似文献

1
Visualizing the invisible: The effect of asymptomatic transmission on the outbreak dynamics of COVID-19.可视化无形之物:无症状传播对新冠疫情动态的影响。
Comput Methods Appl Mech Eng. 2020 Dec 1;372:113410. doi: 10.1016/j.cma.2020.113410. Epub 2020 Sep 8.
2
Visualizing the invisible: The effect of asymptomatic transmission on the outbreak dynamics of COVID-19.可视化无形之物:无症状传播对新冠疫情动态的影响。
medRxiv. 2020 Aug 29:2020.05.23.20111419. doi: 10.1101/2020.05.23.20111419.
3
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.在普通人群中进行 SARS-CoV-2 监测的四种不同策略的有效性和成本效益(CoV-Surv 研究):一项关于集群随机、双因素对照试验的研究方案的结构化总结。
Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z.
4
Role of Asymptomatic COVID-19 Cases in Viral Transmission: Findings From a Hierarchical Community Contact Network Model.无症状新冠病例在病毒传播中的作用:来自分层社区接触网络模型的发现
IEEE Trans Autom Sci Eng. 2021 Sep 3;19(2):576-585. doi: 10.1109/TASE.2021.3106782. eCollection 2022 Apr.
5
The time scale of asymptomatic transmission affects estimates of epidemic potential in the COVID-19 outbreak.无症状传播的时间尺度会影响对新冠疫情爆发中流行潜力的估计。
medRxiv. 2020 Apr 14:2020.03.09.20033514. doi: 10.1101/2020.03.09.20033514.
6
How time-scale differences in asymptomatic and symptomatic transmission shape SARS-CoV-2 outbreak dynamics.无症状和有症状传播的时间尺度差异如何影响 SARS-CoV-2 疫情动态。
Epidemics. 2023 Mar;42:100664. doi: 10.1016/j.epidem.2022.100664. Epub 2023 Jan 10.
7
Modeling the SARS-CoV-2 parallel transmission dynamics: Asymptomatic and symptomatic pathways.模拟新型冠状病毒2型(SARS-CoV-2)的平行传播动态:无症状和有症状传播途径。
Comput Biol Med. 2022 Apr;143:105264. doi: 10.1016/j.compbiomed.2022.105264. Epub 2022 Jan 25.
8
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
9
The time scale of asymptomatic transmission affects estimates of epidemic potential in the COVID-19 outbreak.无症状传播的时间尺度影响着对 COVID-19 疫情中流行潜力的估计。
Epidemics. 2020 Jun;31:100392. doi: 10.1016/j.epidem.2020.100392. Epub 2020 May 11.
10
Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study.干预措施以减轻 SARS-CoV-2 在新加坡的早期传播:一项建模研究。
Lancet Infect Dis. 2020 Jun;20(6):678-688. doi: 10.1016/S1473-3099(20)30162-6. Epub 2020 Mar 23.

引用本文的文献

1
A network-based model to assess vaccination strategies for the COVID-19 pandemic by using Bayesian optimization.一种基于网络的模型,用于通过贝叶斯优化评估针对新冠疫情的疫苗接种策略。
Chaos Solitons Fractals. 2024 Apr;181. doi: 10.1016/j.chaos.2024.114695. Epub 2024 Mar 14.
2
Differentiating Contact with Symptomatic and Asymptomatic Infectious Individuals in a SEIR Epidemic Model.在SEIR传染病模型中区分与有症状和无症状感染个体的接触
Bull Math Biol. 2025 Feb 4;87(3):38. doi: 10.1007/s11538-025-01416-2.
3
Identifying Heterogeneous Micromechanical Properties of Biological Tissues via Physics-Informed Neural Networks.

本文引用的文献

1
Lessons drawn from China and South Korea for managing COVID-19 epidemic: Insights from a comparative modeling study.从中国和韩国管理 COVID-19 疫情中吸取的教训:一项比较建模研究的启示。
ISA Trans. 2022 May;124:164-175. doi: 10.1016/j.isatra.2021.12.004. Epub 2021 Dec 28.
2
Estimation of seroprevalence of novel coronavirus disease (COVID-19) using preserved serum at an outpatient setting in Kobe, Japan: A cross-sectional study.利用日本神户市门诊留存血清估计新型冠状病毒病(COVID-19)血清阳性率:一项横断面研究。
Clin Epidemiol Glob Health. 2021 Jul-Sep;11:100747. doi: 10.1016/j.cegh.2021.100747. Epub 2021 Apr 19.
3
通过物理知识神经网络识别生物组织的异质微观力学特性。
Small Methods. 2025 Jan;9(1):e2400620. doi: 10.1002/smtd.202400620. Epub 2024 Aug 1.
4
A novel strategy to avoid sensitivity loss in pooled testing for SARS-CoV-2 surveillance: validation using nasopharyngeal swab and saliva samples.一种用于避免 SARS-CoV-2 监测中 pooled 检测敏感性损失的新策略:使用鼻咽拭子和唾液样本进行验证。
Front Public Health. 2023 Aug 10;11:1190308. doi: 10.3389/fpubh.2023.1190308. eCollection 2023.
5
Assessing individual risk and the latent transmission of COVID-19 in a population with an interaction-driven temporal model.评估具有相互作用驱动的时变模型的人群中 COVID-19 的个体风险和潜在传播。
Sci Rep. 2023 Aug 10;13(1):12955. doi: 10.1038/s41598-023-39817-9.
6
Seroprevalence of COVID-19 in Oran: Cross-Sectional Study.奥兰 COVID-19 血清流行率:横断面研究。
Microbiol Spectr. 2023 Aug 17;11(4):e0087623. doi: 10.1128/spectrum.00876-23. Epub 2023 Jun 7.
7
Ultra-high field cardiac MRI in large animals and humans for translational cardiovascular research.用于转化心血管研究的大型动物和人类的超高场心脏磁共振成像
Front Cardiovasc Med. 2023 May 15;10:1068390. doi: 10.3389/fcvm.2023.1068390. eCollection 2023.
8
Predicting the spread of covid-19 and the impact of government measures at the early stage of the pandemic: The Dutch case-Stricter but short-term measures are better.预测新冠疫情的传播和政府措施在大流行早期的影响:荷兰案例——更严格但短期的措施更好。
PLoS One. 2023 May 12;18(5):e0283086. doi: 10.1371/journal.pone.0283086. eCollection 2023.
9
The Role of Mobility in the Dynamics of the COVID-19 Epidemic in Andalusia.流动性在安达卢西亚 COVID-19 疫情动态中的作用。
Bull Math Biol. 2023 May 11;85(6):54. doi: 10.1007/s11538-023-01152-5.
10
Backcasting COVID-19: a physics-informed estimate for early case incidence.回溯新冠疫情:基于物理学知识的早期病例发病率估计
R Soc Open Sci. 2022 Dec 14;9(12):220329. doi: 10.1098/rsos.220329. eCollection 2022 Dec.
Infection fatality rate of COVID-19 inferred from seroprevalence data.
基于血清流行率数据推断的 COVID-19 感染病死率。
Bull World Health Organ. 2021 Jan 1;99(1):19-33F. doi: 10.2471/BLT.20.265892. Epub 2020 Oct 14.
4
COVID-19 antibody seroprevalence in Santa Clara County, California.加利福尼亚州圣克拉拉县的新冠病毒抗体血清流行率。
Int J Epidemiol. 2021 May 17;50(2):410-419. doi: 10.1093/ije/dyab010.
5
SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 outbreak in Milan.SARS-CoV-2 血清流行率趋势在 COVID-19 爆发期间在米兰的健康献血者中。
Blood Transfus. 2021 May;19(3):181-189. doi: 10.2450/2021.0324-20. Epub 2021 Feb 3.
6
Global and local mobility as a barometer for COVID-19 dynamics.全球和本地流动性作为 COVID-19 动态的晴雨表。
Biomech Model Mechanobiol. 2021 Apr;20(2):651-669. doi: 10.1007/s10237-020-01408-2. Epub 2021 Jan 15.
7
Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020.2020 年 4 月伊朗吉兰省 SARS-CoV-2 的血清流行率。
Emerg Infect Dis. 2021 Feb;27(2):636-638. doi: 10.3201/eid2702.201960. Epub 2020 Dec 21.
8
Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020.检测 SARS-CoV-2 的中和抗体以确定 2020 年 3 月至 5 月间苏格兰献血人群的暴露情况。
Euro Surveill. 2020 Oct;25(42). doi: 10.2807/1560-7917.ES.2020.25.42.2000685.
9
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood.SARS-CoV-2 血清阳性率及中和活性在供者和患者血液中的变化。
Nat Commun. 2020 Sep 17;11(1):4698. doi: 10.1038/s41467-020-18468-8.
10
SARS-CoV-2 Antibody Seroprevalence in Industry Workers in Split-Dalmatia and Šibenik-Knin County, Croatia.克罗地亚斯普利特-达尔马提亚省和希贝尼克-克宁县工业工人中 SARS-CoV-2 抗体血清阳性率。
J Occup Environ Med. 2021 Jan 1;63(1):32-37. doi: 10.1097/JOM.0000000000002020.